Developmental Therapeutics Core

    Equipment/facility: Facility

    • Location

      2170 Campus Dr. Silverman Hall B715 Evanston, IL 60208

    Description

    Developmental Therapeutics Core (DTC) provides a range of preclinical testing services that include: in vitro tumor cell assays; in vivo subcutaneous and orthotopic models for studying tumor growth, as well as for studying tumor response to therapy; exploratory pharmacokinetics; and exploratory toxicology. The DTC also assists investigators with drug formulations and initial assessments of drug stability. A patient-derived xenograft (PDX) repository provides investigators with more than 60 tumor models representing 12 different types of cancer for in vivo testing of therapies against human tumors. The DTC also maintains a repository with more than 200 human tumor cell lines, many of which can also be used for xenograft establishment and therapeutic testing. DTC staff are proficient in all routes of treatment administration and in small animal surgery, provide consulting and training, and accelerate implementation of studies through simple modification of blanket IACUC protocols. Experienced core staff advise faculty on study design, and assist with the interpretation and presentation of results for manuscripts and grant applications.

    Fingerprint

    Neoplasms
    Therapeutics
    Heterografts
    Animal Care Committees
    Research Personnel
    Drug Stability
    Drug Compounding
    Manuscripts
    Organized Financing
    Tumor Cell Line
    Toxicology
    Pharmacokinetics
    Growth
    In Vitro Techniques

    Categories

    • Animal Preclinical Services
    • Consultation
    • Sample Preparation
    • Specimen Preparation
    • Training

    Resources

    • In-vivo Tumor Model (Xenograft)
    • Patient-Derived Xenograft (PDX) Tumor Models
    • Proliferation and Apoptosis Assays
    • Exploratory Pharmacokinetics and Toxicology
    • Device Implantation and Monitoring